BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 4598755)

  • 1. Effects of morphine on striatal dopamine metabolism: possible mechanism of its opposite effect on locomotor activity in rats and mice.
    Kuschinsky K; Hornykiewicz O
    Eur J Pharmacol; 1974 Apr; 26(1):41-50. PubMed ID: 4598755
    [No Abstract]   [Full Text] [Related]  

  • 2. Morphine catalepsy in the rat: relation to striatal dopamine metabolism.
    Kuschinsky K; Hornykiewicz O
    Eur J Pharmacol; 1972 Jul; 19(1):119-22. PubMed ID: 5065530
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of dopamine in pilocarpine-induced catalepsy.
    Ahtee L; Kääriäinen I
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 284(1):25-38. PubMed ID: 4279348
    [No Abstract]   [Full Text] [Related]  

  • 4. Antagonism of the effects of chlorpromazine and morphine on dopamine metabolism by GABA.
    Lahti RA; Losey EG
    Res Commun Chem Pathol Pharmacol; 1974 Jan; 7(1):31-40. PubMed ID: 4811457
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of muscarinic cholinergic drugs on morphine-induced catalepsy, antinociception and changes in brain dopamine metabolism.
    Kaakkola S; Ahtee L
    Psychopharmacology (Berl); 1977 Mar; 52(1):7-15. PubMed ID: 403561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of mecamylamine on the fate of dopamine in striatal and mesolimbic areas of rat brain; interaction with morphine and haloperidol.
    Ahtee L; Kaakkola S
    Br J Pharmacol; 1978 Feb; 62(2):213-8. PubMed ID: 564219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of catecholamines for the manifestation of morphine withdrawal in the rat].
    Bläsig J; Papeschi R; Herz A
    Arzneimittelforschung; 1974 Jul; 24(7):1015-6. PubMed ID: 4408108
    [No Abstract]   [Full Text] [Related]  

  • 8. Regulation of striatal acetylcholine concentration by dopamine receptors.
    Sethy VH; Van Woert MH
    Nature; 1974 Oct; 251(5475):529-30. PubMed ID: 4421728
    [No Abstract]   [Full Text] [Related]  

  • 9. Biochemical and behavioral antagonism between fenfluramine and apomorphine in rats.
    Jori A; Cecchetti G; Ghezzi D; Samanin R
    Eur J Pharmacol; 1974 May; 26(2):179-83. PubMed ID: 4859224
    [No Abstract]   [Full Text] [Related]  

  • 10. Catecholamine receptor agonists: effects on motor activity and rate of tyrosine hydroxylation in mouse brain.
    Strömbom U
    Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(2):167-76. PubMed ID: 181681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition by apomorphine of the metoclopramide-induced catalepsy and increase in striatal homovanillic acid content.
    Ahtee L
    Br J Pharmacol; 1975 Nov; 55(3):381-5. PubMed ID: 1239323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioural, pharmacological and biochemical effects of acute and chronic administration of ketamine in the rat.
    Lannes B; Micheletti G; Warter JM; Kempf E; Di Scala G
    Neurosci Lett; 1991 Jul; 128(2):177-81. PubMed ID: 1945038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of drugs on metoclopramide-induced catalepsy and increase in striatal homovanillic acid content.
    Ahtee L
    Br J Pharmacol; 1975 Mar; 53(3):460P. PubMed ID: 1169083
    [No Abstract]   [Full Text] [Related]  

  • 14. Stimulation and inhibition of serotoninergic mechanisms in rat brain: alterations of morphine effects on striatal dopamine metabolism and on motility.
    Groppe G; Kuschinsky K
    Neuropharmacology; 1975 Sep; 14(9):659-64. PubMed ID: 1080841
    [No Abstract]   [Full Text] [Related]  

  • 15. An ontogenic study on the effect of catecholamine receptor-stimulating agents on the turnover of noradrenaline and dopamine in the brain.
    Kellogg C; Wennerström G
    Brain Res; 1974 Oct; 79(3):451-64. PubMed ID: 4371328
    [No Abstract]   [Full Text] [Related]  

  • 16. Apomorphine induced biting and fighting behaviour in reserpinized rats and an approach to the mechanism of action.
    Patni SK; Dandiya PC
    Life Sci; 1974 Feb; 14(4):737-45. PubMed ID: 4856759
    [No Abstract]   [Full Text] [Related]  

  • 17. Interactions between ibogaine, a potential anti-addictive agent, and morphine: an in vivo microdialysis study.
    Maisonneuve IM; Keller RW; Glick SD
    Eur J Pharmacol; 1991 Jun; 199(1):35-42. PubMed ID: 1893925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerance phenomena with neuroleptics catalepsy, apomorphine stereotypies and striatal dopamine metabolism in the rat after single and repeated administration of loxapine and haloperidol.
    Asper H; Baggiolini M; Burki HR; Lauener H; Ruch W; Stille G
    Eur J Pharmacol; 1973 Jun; 22(3):287-94. PubMed ID: 4738903
    [No Abstract]   [Full Text] [Related]  

  • 19. Antagonism by alpha-methyltyrosine of morphine induced motility in non-tolerant and tolerant rats.
    Davis WM; Babbini M; Khalsa HJ
    Res Commun Chem Pathol Pharmacol; 1972 Sep; 4(2):267-79. PubMed ID: 5074526
    [No Abstract]   [Full Text] [Related]  

  • 20. Indirect activation of the DA system as a possible mechanism for the stimulatory effects of narcotic analgesics.
    Di Chiara G; Vargiu L; Porceddu ML; Longoni R; Mulas A; Gessa GL
    Adv Biochem Psychopharmacol; 1977; 16():571-5. PubMed ID: 18901
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.